RegenMed, Inc. operates as a National Science Foundation-funded innovation ecosystem that helps regenerative medicine companies develop, grow, and scale their technologies. The organization provides resources, expertise, and collaboration opportunities to bridge industry, workforce development, and science in order to accelerate commercial applications.
Subscribe to see RegenMed, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
RegenMed, Inc. is a regenerative medicine company headquartered in Greenwich, United States. Its most recent funding round raised $290,000 in February 2025. Xcout tracks 25 named people at RegenMed, Inc., including Michael Paul Tierney (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
19 more named people on record for RegenMed, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $290,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of RegenMed, Inc.'s closest competitors — see the full list of competitors and alternatives →
CCRM Enterprises Holdings Ltd. acts as a catalyst for commercializing regenerative medicines and cell and gene therapies. The organization bridges academia and industry by providing stakeholders, expertise, specialized infrastructure, and funding to accelerate product development and launch companies.
Regen Development LLC provides a digital infrastructure and operating system that enables communities, land stewards, scientists, and institutions to coordinate, fund, and verify ecological regeneration. The company offers tools including a public ledger, a registry for ecological credit programs, and a marketplace for buying and selling verified ecocredits.
TissueForm, Inc. is headquartered in Boulder, Colorado, and focuses on regenerative medicine and plastic surgery. The company has developed a novel biomaterial designed to address clinical problems and adapt across multiple applications.
GenesisTissue Inc. is a 3D bioprinting tissue company based at the CSU Spur campus in Denver, Colorado. The biotech startup designs and manufactures personalized regenerative tissue implants for humans.
NellOne Therapeutics develops regenerative-medicine therapies based on NELL-1, a protein associated with bone formation and regeneration. Its work is aimed at treating bone defects and related orthopedic conditions for patients and healthcare providers.
The ERC Program, supported by the National Science Foundation, funds and oversees Engineering Research Centers that advance technology across sectors such as advanced manufacturing, biotechnology, energy, and microelectronics. It serves researchers, students, and industry partners by promoting engineering research, translational innovation, and workforce development.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about RegenMed, Inc.? Suggest a correction · Work at RegenMed, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.